DICAM-SPECIFIC ANTIBODIES AND USES THEREOF
    3.
    发明公开
    DICAM-SPECIFIC ANTIBODIES AND USES THEREOF 审中-公开
    DICAM特异性抗体及其用途

    公开(公告)号:EP3233919A1

    公开(公告)日:2017-10-25

    申请号:EP15868788.9

    申请日:2015-12-17

    摘要: Novel antibodies directed against Dual Ig domain containing cell adhesion molecule (DICAM) are described. These anti-DICAM antibodies are capable of detecting DICAM by Western blot and/or flow cytometry, blocking the interaction between DICAM and its ligand αVβ3 integrin, and/or blocking the migration of inflammatory cytokine-secreting TH17 lymphocytes across the blood brain barrier. Uses of these antibodies or compositions comprising same for the diagnosis, prevention and/or treatment of autoimmune/inflammatory conditions, such as neuroinflammatory conditions, and for the targeting, identification and selection of inflammatory cytokine-secreting TH17 lymphocytes or precursor thereof are also disclosed.

    摘要翻译: 描述了针对含双Ig结构域的细胞粘附分子(DICAM)的新型抗体。 这些抗DICAM抗体能够通过Western印迹和/或流式细胞术检测DICAM,阻断DICAM与其配体αVβ3整联蛋白之间的相互作用,和/或阻断分泌炎性细胞因子的T H17淋巴细胞穿过血脑屏障的迁移 。 这些抗体或包含它们的组合物用于诊断,预防和/或治疗自身免疫性/炎症性病症如神经炎症病症以及用于靶向,鉴定和选择分泌炎性细胞因子的T H17淋巴细胞或其前体也被公开 。